REQUEST A DEMO
Total
USD $0.00
Search more companies

Martyn-Drog Sp. z o.o. (Poland)

Main Activities: Highway, Street, and Bridge Construction
Full name: Martyn-Drog Sp. z o.o. Profile Updated: April 04, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Martyn-Drog Sp. z o.o. is an enterprise based in Poland. Its main office is in Rzasiny. It operates in the Highway, Street, and Bridge Construction industry. The enterprise was incorporated on December 18, 2020. From the latest financial highlights, Martyn-Drog Sp. z o.o. reported a net sales revenue increase of 109.87% in 2024. A growth of 112.22% was recorded in its total assets. The net profit margin of Martyn-Drog Sp. z o.o. decreased by 4.25% in 2024.

Headquarters
Rzasiny 103
Rzasiny; Dolnoslaskie; Postal Code: 59-620

Contact Details: Purchase the Martyn-Drog Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Martyn-Drog Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Martyn-Drog Sp. z o.o. report to view the information.
Incorporation Date:
December 18, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Martyn-Drog Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
109.87%
Total operating revenue
95.57%
Operating profit (EBIT)
99.25%
EBITDA
82.26%
Net Profit (Loss) for the Period
88.36%
Total Assets
112.22%
Total Equity
101.68%
Operating Profit Margin (ROS)
-2.13%
Net Profit Margin
-4.25%
Return on Equity (ROE)
-5.26%
Quick Ratio
-2.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?